Efficien t Con ver sion of Su bstitu ted Ar yl
Th iou r ea s to 2-Am in oben zoth ia zoles Usin g
Ben zyltr im eth yla m m on iu m Tr ibr om id e
Alfonzo D. J ordan,* Chi Luo, and Allen B. Reitz
usually proceeds efficiently at room temperature, several
drawbacks are associated with the use of liquid bromine,
which is a highly toxic and corrosive reagent, and can
be difficult to manipulate on small scale. As an alterna-
tive reagent to liquid bromine, organic ammonium tri-
bromides (OATBs) such as benzyltrimethylammonium
tribromide (1, PhCH2NMe3Br3) and tetrabutylammonium
tribromide (2, Bu4NBr3) are high molecular weight,
stable, crystalline solids, which can deliver a stoichio-
metric amount of bromine where small amounts are
necessary for microscale reactions. For example, Bu4NBr3
and PhCH2NMe3Br3 are effective alternatives to bromine
for the bromination of activated aromatic substrates,12-14
alkenes,14 and ketones.15 To date, OATBs have not been
reported as a substitute for bromine in the preparation
of 2-alkylaminobenzothiazoles from arylthioureas. Herein,
we describe an efficient method for the facile conversion
of aryl thioureas to 2-aminobenzothiazoles with an
equimolar amount of PhCH2NMe3Br3 under a variety of
reaction conditions. In addition, this reagent has been
used to prepare 2-aminobenzothiazoles via a one-pot
procedure from isothiocyanates and amines or a substi-
tuted aniline and tetrabutylammonium thiocyanate (Bu4-
NSCN).
Drug Discovery Division, J ohnson & J ohnson
Pharmaceutical Research and Development,
P.O. Box 0776, Welsh and McKean Roads,
Spring House, Pennsylvania 19477-0776
ajordan@prdus.jnj.com
Received J uly 1, 2003
Abstr a ct: The reaction of molecular bromine (Br2) with
arylthioureas is known to produce 2-aminobenzothiazoles
(Hugerschoff reaction). We show here that benzyltrimethy-
lammonium tribromide (1, PhCH2NMe3Br3), a stable, crys-
talline organic ammonium tribromide (OATB), can be readily
utilized as an alternative electrophilic bromine source. It is
easier to control the stoichiometry of addition with an OATB,
which minimizes aromatic bromination caused by excess
reagent. We have developed a direct procedure from isothio-
cyanates and amines using tetrabutylammonium thiocyan-
ate (Bu4NSCN) and PhCH2NMe3Br3 to afford functionalized
2-aminobenzothiazoles.
2-Aminobenzothiazoles are broadly found in bioorganic
and medicinal chemistry with applications in drug dis-
covery and development for the treatment of diabetes,1
epilepsy,2,3,4 inflammation,5 amyotrophic lateral sclero-
sis,6 analgesia,7 tuberculosis,8 and viral infections.9 In-
vestigations into the preparation of 2-aminobenzothiaz-
oles can be traced to the early 1900s with the work of
Hugerschoff, who found that an arylthiourea can be
cyclized with liquid bromine in chloroform to form an
2-aminobenzothiazole (eq 1).10,11 Although this reaction
Resu lts a n d Discu ssion
During the course of a medicinal chemistry project, we
needed to prepare a series of 2-aminobenzothiazoles and
initially used the method of Ambati and co-workers who
reported a facile synthesis from substituted arylthioureas
and bromine in acetic acid at room temperature.16 They
had reported that N-methyl-N′-phenylthiourea 3 under-
went oxidative cyclization with 1.95 molar equiv of
bromine in acetic acid at room temperature to provide
2-(methylamino)benzothiazole 4 in 75% yield (Table 1,
entry 1). When we repeated this experiment, we obtained
6-bromobenzothiazole 518 in 46% isolated yield with only
* To whom correspondence should be addressed. Phone: 215-628-
5638. Fax: 215-628-4985.
(1) Suter, H.; Zutter, H. Helv. Chim. Acta 1967, 50, 1084.
(2) Hays, S. J .; Rice, M. J .; Ortwine, D. F.; J ohnson, G.; Schwartz,
R. D.; Boyd, D. K.; Copeland, L. F.; Vartanian, M. G.; Boxer, P. A. J .
Pharm. Sci. 1994, 83, 1425.
(3) J imonet, P.; Audiau, F.; Barreau, M.; Blanchard, J .-C.; Boireau,
A.; Bour, Y.; Coleno, M.-A.; Doble, A.; Doerflinger, G., Huu, C. D.;
Donat, M.-H.; Duchesne, J . M.; Ganil, P., Gueremy, C., Honore, E.,
J ust, B.; Kerphirique, R., Gontier, S.; Hubert, P.; Laduron, P. M.; Le
Blevec, J .; Meunier, M.; Miquet, J .-M.; Nemecek, C.; Pasquet, M.; Piot,
O.; Pratt, J .; Rataud, J .; Reibaud, M.; Stutzmann, J .-M.; Mignani, S.
J . Med. Chem. 1999, 42, 2828.
(4) He, Y.; Benz, A.; Fu, T.; Wang, M.; Covey, D. F.; Zorumski, C.
F.; Mennick, S. Neuropharmacology 2002, 42, 199.
(5) Sawhney, S. N.; Arora, S. K.: Singh, J . V.; Bansal, O. P.; Singh,
S. P. Indian J . Chem. 1978, 16B, 605.
(11) Sprague, J . M.; Land, A. H. In Heterocyclic Compounds;
Elderfield, R. C., Ed.; J . Wiley: New York, 1957; Vol. 5, Chapter 8, pp
484-721.
(12) Kajigaeshi, S.; Kakinami, T.; Okamoto, T.; Nakamura, H.;
Fujikawa, M. Bull. Chem Soc. J pn. 1987, 60, 4187.
(13) Kajigaeshi, S.; Kakinami, T.; Yamasaki, H.; Hiromichi, F.;
Fujisaki, S.; Okamoto, T. Bull. Chem Soc. J pn. 1988, 61, 2681.
(14) Chaudhuri, M. K.; Khan, A. T.; Patel, B. K.; Dey, D.; Kharma-
wophlang, W.; Lakshmiprabha, T. R.; Mandal, G. C. Tetrahedron Lett.
1998, 39, 816.
(6) Bensimon, G.; Lacomblez, L.; Meininger, V. New Engl. J . Med.
1994, 330, 585.
(7) Foscolos, G.; Tsatsas, G.; Champagnac, A.; Pommier, M. Ann.
Pharm. Fr. 1977, 35, 295.
(8) Shirke, V. G.; Bobade.; Bhamaria, R. P.; Khadse, B. G.; Sengupta,
S. R. Indian Drugs 1990, 27(6), 350.
(15) Kajigaeshi, S.; Kakinami, T.; Hajime, H.; Okamoto, T.; Naka-
mura, H. Bull. Chem Soc. J pn. 1987, 60, 2667.
(16) Ambati, N. B.; Anad, V.; Hanumanthu, P. Synth. Commun.
1997, 27, 1487.
(17) We believe that the earlier work16 had actually produced 5 and
(9) Paget, C. J .; Kisner, K.; Stone, R. L.; Delong, D. C. J . Med. Chem.
1969, 12, 1016.
(10) Hugerschoff, H. Chem. Ber. 1901, 34, 3130. (b) Hugerschoff,
H. Chem. Ber. 1903, 36, 3121.
not 4 and that this product had been improperly characterized.
Consistent with this analysis is our observation that the melting point
we found for 5 (227-228 °C) is closer to what was reported (215 °C)
than the melting point for 4 (140-141 °C).
10.1021/jo0349431 CCC: $25.00 © 2003 American Chemical Society
Published on Web 10/03/2003
J . Org. Chem. 2003, 68, 8693-8696
8693